share_log

NKGEN BIOTECH | 4: Statement of changes in beneficial ownership of securities-Director Klowden Michael

SEC ·  Feb 15 09:13
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more